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ABCD progression post 
crosslinking for Keratoconus 
Sonali Patel, Dr. Neil Vadhar, Dr. Zeba Syed 
Introduction
• Keratoconus à corneal disease
– Cornea thins out and becomes cone shaped  
• Most common treatment à Cross Linking
– Riboflavin drops are placed on the patients eyes and allowed to sit
– The treated eye is then exposed to UV light 
• increases the degree of interfibrillar collagen cross linking
• Extra strength from cross linking can help stop the progression of keratoconus. 
Introduction
• Post-surgical outcomes of cross linking à traditionally 
analyzed using an AK (Amsler- Krumeich) system
– Could not account for posterior corneal surface and corneal thickness)
• New ABCD classification was developed
– Takes into account anterior (A) and posterior (B) radius of curvature, 
the thinnest corneal pachymetry (C) and the distance for best 
corrected vision (D)
– Data collected via Pentamcam
• extra information should help describe the keratoconic cornea 





– How do ABCD measurements fluctuate with the changes in visual 
acuity post cross linking surgery?
• Hypothesis
– ABCD measurements should all decrease post cross linking surgery 
Approach & Results
• A retrospective study was done using 104 patients who 
underwent CXL treatment for keratoconus at Wills Eye 
between 1/2016 and 6/2019
• previous Lasix surgery was an exclusion criteria 
– corneas might show different post-surgical changes
• Measurements were taken using a Pentacam. 
– pre-operatively 
– post operatively at months 3 and 6
– D value not readily available for all of the patients and thus 
was not collected.
– Increases in these measurements à disease progression
– decreases à Disease regression
Approach & Results
Conclusions
• A, B and C à initially progressed post-operatively at 3 
months
– B and C values progresses to a much higher degree than A 
value
– 6 months post operatively: 
• A values regressed past baseline
• B and C values also regressed but not past baseline.
• CXL surgery à improves keratoconus in the anterior 
cornea but not as effective in the posterior cornea
• Initial regression in the B and C value ànot a concern
– stabilize later than the A value
– does not mean that the CXL surgery was unsuccessful
Future Directions
• Longer follow up times:
– looking at patient data at 9 or 12 months could 
help pinpoint when the posterior chamber and 
corneal thickness stabilize in disease progression.
• Increased sample size
– the amount of eyes looked at was relatively small
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